Literature DB >> 21335128

Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry.

Eckhard Mayer1, David Jenkins, Jaroslav Lindner, Andrea D'Armini, Jaap Kloek, Bart Meyns, Lars Bo Ilkjaer, Walter Klepetko, Marion Delcroix, Irene Lang, Joanna Pepke-Zaba, Gerald Simonneau, Philippe Dartevelle.   

Abstract

OBJECTIVE: Pulmonary endarterectomy is a curative surgical treatment option for the majority of patients with chronic thromboembolic pulmonary hypertension. The current surgical management and postoperative outcome of patients enrolled in an international registry on chronic thromboembolic pulmonary hypertension were investigated.
METHODS: The registry included newly diagnosed (≤6 months) consecutive patients with chronic thromboembolic pulmonary hypertension from February 2007 to January 2009.
RESULTS: A total of 679 patients were registered from 1 Canadian and 26 European centers, of whom 386 (56.8%) underwent surgery. The median age of patients undergoing surgery was 60 years, and 54.1% were male. Previous pulmonary embolism was confirmed for 79.8% of patients. Perioperative complications occurred in 189 patients (49.2%): infection (18.8%), persistent pulmonary hypertension (16.7%), neurologic (11.2%) or bleeding (10.2%) complications, pulmonary reperfusion edema (9.6%), pericardial effusion (8.3%), need for extracorporeal membrane oxygenation (3.1%), and in-hospital mortality due to perioperative complications (4.7%). Documented 1-year mortality was 7%. Preoperative exercise capacity was predictive of 1-year mortality. Postoperative pulmonary vascular resistance predicted in-hospital and 1-year mortality. In patients evaluated within 1 year after surgery, the median pulmonary vascular resistance had decreased from 698 to 235 dyn x s x cm(-5) (95% confidence limit, 640-874 and 211-255, respectively, n = 70) and the median 6-minute walk distance had increased from 362 to 459 m (95% confidence limit, 340-399 and 440-473, respectively, n = 168). New York Heart Association functional class improved with most patients progressing from class III/IV to class I/II.
CONCLUSIONS: Pulmonary endarterectomy is associated with a low in-hospital mortality rate and improvements in hemodynamics and exercise capacity.
Copyright © 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21335128     DOI: 10.1016/j.jtcvs.2010.11.024

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  131 in total

1.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Novel Insights and Treatment Strategies for Right Heart Failure.

Authors:  Weiqin Lin; Ai-Ling Poh; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2018-06

3.  Pulmonary endarterectomy surgery--a technically demanding cure for WHO Group IV Pulmonary Hypertension: requirements for centres of excellence and availability in Canada.

Authors:  John J Ryan; Stuart Rich; Stephen L Archer
Journal:  Can J Cardiol       Date:  2011-10-22       Impact factor: 5.223

4.  Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.

Authors:  John E Cannon; Li Su; David G Kiely; Kathleen Page; Mark Toshner; Emilia Swietlik; Carmen Treacy; Anie Ponnaberanam; Robin Condliffe; Karen Sheares; Dolores Taboada; John Dunning; Steven Tsui; Choo Ng; Deepa Gopalan; Nicholas Screaton; Charlie Elliot; Simon Gibbs; Luke Howard; Paul Corris; James Lordan; Martin Johnson; Andrew Peacock; Robert MacKenzie-Ross; Benji Schreiber; Gerry Coghlan; Kostas Dimopoulos; Stephen J Wort; Sean Gaine; Shahin Moledina; David P Jenkins; Joanna Pepke-Zaba
Journal:  Circulation       Date:  2016-04-06       Impact factor: 29.690

5.  Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Authors:  Colm McCabe; Maxine Bennett; Natalie Doughty; Robert MacKenzie Ross; Linda Sharples; Joanna Pepke-Zaba
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

Review 6.  Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options.

Authors:  Stephan Rosenkranz
Journal:  Clin Res Cardiol       Date:  2014-12-06       Impact factor: 5.460

7.  [Cor pulmonale and pulmonary hypertension. Update after the world conference in Nice].

Authors:  S Rosenkranz
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

Review 8.  Chronic thromboembolic pulmonary hypertension.

Authors:  Karen M Olsson; Bernhard Meyer; Jan Hinrichs; Jens Vogel-Claussen; Marius M Hoeper; Serghei Cebotari
Journal:  Dtsch Arztebl Int       Date:  2014-12-12       Impact factor: 5.594

9.  Prediction of hemodynamic improvement after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension using non-invasive imaging.

Authors:  Bastiaan E Schölzel; Martijn C Post; Alexander van de Bruaene; Steven Dymarkowski; Wim Wuyts; Bart Meyns; Werner Budts; Marion Delcroix
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-22       Impact factor: 2.357

Review 10.  Pulmonary hypertension: diagnostic approach and optimal management.

Authors:  Nathan Hambly; Fahad Alawfi; Sanjay Mehta
Journal:  CMAJ       Date:  2016-05-02       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.